Cargando…
Serum CA-125 and renal impairment in patients undergoing hyperthermic intraperitoneal chemotherapy
Autores principales: | Bernal-Bello, David, Guerra-Pérez, Ignacio, Alegre-Zahonero, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chang Gung University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661511/ https://www.ncbi.nlm.nih.gov/pubmed/34902619 http://dx.doi.org/10.1016/j.bj.2021.12.002 |
Ejemplares similares
-
Reply: Serum CA-125 and renal impairment in patients undergoing hyperthermic intraperitoneal chemotherapy
por: Chen, Wei-Chun, et al.
Publicado: (2022) -
Influence of hyperthermic intraperitoneal chemotherapy on renal blood perfusion
por: Liesenfeld, Lukas F., et al.
Publicado: (2023) -
Temperature management during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
por: Ramirez, Maria F., et al.
Publicado: (2023) -
Anesthetic implications in hyperthermic intraperitoneal chemotherapy
por: Gupta, Nishkarsh, et al.
Publicado: (2019) -
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
por: Riggs, McKayla J., et al.
Publicado: (2020)